Broodkruimel
Documenten en Media
Self-management interventions for adults living with Chronic Obstructive Pulmonary Disease (COPD)- The development of a Core Outcome Set for COMPAR-EU project
Self-management interventions for adults living with Chronic Obstructive Pulmonary Disease (COPD)- The development of a Core Outcome Set for COMPAR-EU project
Versie 1.1 Goedgekeurd
- Documenttype
- EXTERNAL_DOCUMENT
- Extensie
- png
- Grootte
- 120 kB
- Gewijzigd
- 21-10-22 13:44 door mir mir
- Gemaakt
- 21-10-22 13:43 door mir mir
- Locatie
- PUBLIC
- Waarderingen
-
-
Versie 1.1Door mir mir, over 21-10-22 13:44Geen wijzigingslogboek
-
Versie 1.0Door mir mir, over 21-10-22 13:43Geen wijzigingslogboek
Samenvatting
Background: A large body of evidence suggests that self-management interventions (SMIs) may improve outcomes in chronic obstructive pulmonary disease (COPD). However, accurate comparisons of the relative effectiveness of SMIs are challenging, partly due to heterogeneity of outcomes across trials and uncertainty about the importance of these outcomes for patients. We aimed to develop a core set of patient-relevant outcomes (COS) for SMIs trials to enhance comparability of interventions and ensure person-centred care.
Methods: We undertook an innovative approach consisting of four interlinked stages: i) Development of an initial catalogue of outcomes from previous EU-funded projects and/or published studies, ii) Scoping review of reviews on patients and caregivers’ perspectives to identify outcomes of interest, iii) Two-round Delphi online survey with patients and patient representatives to rate the importance of outcomes, and iv) Face-to-face consensus workshop with patients, patient representatives, health professionals and researchers to develop the COS.
Results: From an initial list of 79 potential outcomes, 16 were included in the COS plus one supplementary outcome relevant to all participants. These were related to patient and car knowledge/competence, self-efficacy, patient activation, self-monitoring, adherence, smoking cessation, COPD symptoms, physical activity, sleep quality, caregiver quality of life, activities of daily living, coping with the disease, participation and decision-making, emergency room visits/admissions and cost effectiveness.
Conclusion: The development of the COPD COS for the evaluation of SMIs will increase consistency in the measurement and reporting of outcomes across trials. It will also contribute to more personalized health care and more informed health decisions in clinical practice as patients’ preferences regarding COPD outcomes are more systematically included.

Het COMPAR-EU project heeft financiering ontvangen van het Horizon 2020 onderzoeks- en innovatieprogramma van de Europese Unie in het kader van subsidie overeenkomst nummer 754936.
Houd er rekening mee dat dit de bètaversie van het COMPAR-EU-platform is. Het bevat nu de voltooide resultaten voor Diabetes Type 2 en gedurende de zomer van 2022 zullen de resultaten voor obesitas, COPD en hartfalen worden voltooid. Ook wordt het platform de komende maanden uitgebreid en verbeterd.